aceclofenac has been researched along with Rheumatoid Arthritis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R; Negi, S; Sharma, P; Tandel, N; Tyagi, RK | 1 |
| Akhverdyan, YR; Papichev, EV; Polyakova, YV; Sivordova, LE; Zavodovsky, BV | 1 |
| Poorvashree, J; Suneela, D | 1 |
| Biju, IK; Manappallil, RG; Peringat, J; Prasan, D | 1 |
| Ramasamy, T; Ruttala, HB; Shanmugam, S; Umadevi, SK | 1 |
| Pragada, RR; Sanka, K; Veerareddy, PR | 1 |
| Garg, NK; Goni, VG; Kapil, N; Katare, OP; Pareek, A; Raza, K; Saini, MK; Sharma, G; Thakur, K | 1 |
| Legrand, E | 1 |
| Ansoleaga, JJ; Gijón-Baños, J; Martín-Mola, E | 1 |
| Bowdler, J; Kornasoff, D; Maisenbacher, J; Raber, A | 1 |
| Ferrer, F; Marcolongo, R; Parnham, MJ; Pasero, G; Serni, U | 1 |
| Balaguer, XG; Hunter, JA; Parnham, MJ | 1 |
| Alonso-Ruiz, A; Ansoleaga, JJ; Perez-Ruiz, F | 1 |
| Hashimoto, S; Kaneda, N; Kawai, S; Koshino, T; Matsuzaki, T; Mizushima, Y; Okamoto, R; Yamazaki, R; Yokokura, T | 1 |
| Hashimoto, S; Kawai, S; Koshino, T; Matsumoto, T; Matsuzaki, T; Mizushima, Y; Okamoto, R; Yamazaki, R; Yokokura, T | 1 |
| Llenas, J | 1 |
| Hashimoto, S; Ito, A; Kawai, S; Matsuzaki, T; Mizushima, Y; Yamazaki, R; Yokokura, T | 1 |
| Henrotin, Y; Paul, I; Reginster, JY | 1 |
| Badia, X; Brosa, M; Martínez, E; Peris, F | 1 |
3 review(s) available for aceclofenac and Rheumatoid Arthritis
| Article | Year |
|---|---|
Aceclofenac and methotrexate combination therapy could influence Th1/Th17 axis to modulate rheumatoid-arthritis-induced inflammation.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Drug Therapy, Combination; Inflammation; Methotrexate; Mice | 2023 |
Aceclofenac in the management of inflammatory pain.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac; Humans; Inflammation; Osteoarthritis; Pain; Spondylitis, Ankylosing | 2004 |
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cartilage; Chronic Disease; Diclofenac; Humans; Inflammation; Osteoarthritis; Pain; Spondylitis, Ankylosing | 2001 |
5 trial(s) available for aceclofenac and Rheumatoid Arthritis
| Article | Year |
|---|---|
Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Drug Tolerance; Female; Humans; Ketoprofen; Male; Middle Aged; Pain; Prospective Studies | 1995 |
The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis.
Topics: Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Elasticity; Female; Hand Strength; Heartburn; Humans; Indomethacin; Joints; Male; Middle Aged; Pain Measurement; Statistics, Nonparametric; Treatment Outcome; Vertigo | 1996 |
A multi-centre, double-blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Long-Term Care; Male; Middle Aged; Pain Measurement; Range of Motion, Articular; Treatment Outcome | 1995 |
Aceclofenac in rheumatoid arthritis: a useful and novel anti-inflammatory.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Range of Motion, Articular; Treatment Outcome | 1996 |
Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Piroxicam | 1996 |
11 other study(ies) available for aceclofenac and Rheumatoid Arthritis
| Article | Year |
|---|---|
[Assessment of the safety, tolerability and effectiveness of first Russian generic aceclofenac in patients with undifferentiated peripheral inflammatory arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Female; Humans; Male; Russia | 2020 |
Novel drug delivery of dual acting prodrugs of hydroxychloroquine with aryl acetic acid NSAIDs: Design, kinetics and pharmacological study.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rheumatoid; Carrageenan; Diclofenac; Drug Design; Female; Freund's Adjuvant; Hydroxychloroquine; Inflammation; Male; Mice; Prodrugs; Pyrroles; Rats; Rats, Wistar | 2017 |
Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Cells; Bone Marrow Diseases; Diclofenac; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Methotrexate; Oral Ulcer | 2018 |
Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rheumatoid; Calorimetry, Differential Scanning; Coated Materials, Biocompatible; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Chronotherapy; Drug Compounding; Drug Stability; Gastric Juice; Intestinal Secretions; Male; Microspheres; Particle Size; Pectins; Polymethacrylic Acids; Rats; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tissue Distribution | 2013 |
A pH-triggered delayed-release chronotherapeutic drug delivery system of aceclofenac for effective management of early morning symptoms of rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Carrageenan; Diclofenac; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Male; Microspheres; Pregnancy; Rats; Rats, Wistar; Syndrome | 2015 |
Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical study.
Topics: Animals; Arthritis, Rheumatoid; Delayed-Action Preparations; Diclofenac; Edema; Humans; Inflammation; Liposomes; Lysine; Mice; Nanoparticles; Rats; Skin; Xylenes | 2017 |
Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Chromatography, Thin Layer; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Humans; Interleukin-1; Isoenzymes; Membrane Proteins; Monocytes; Neutrophils; Prostaglandin-Endoperoxide Synthases; Synovial Membrane | 1997 |
Hydrolytic activity is essential for aceclofenac to inhibit cyclooxygenase in rheumatoid synovial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blotting, Western; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Humans; Hydrolysis; Immunoenzyme Techniques; Isoenzymes; Membrane Proteins; Microsomes; Prostaglandin-Endoperoxide Synthases; Synovial Membrane | 1999 |
Aceclofenac: is the antiinflammatory effect really due to cyclooxygenase inhibition?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Chondrocytes; Diclofenac; Humans; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Sensitivity and Specificity | 1999 |
A major metabolite of aceclofenac, 4'-hydroxy aceclofenac, suppresses the production of interstitial pro-collagenase/proMMP-1 and pro-stromelysin-1/proMMP-3 by human rheumatoid synovial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Dinoprostone; Enzyme Precursors; Extracellular Space; Humans; Interleukin-1; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Protease Inhibitors; RNA, Messenger; Synovial Membrane; Tissue Inhibitor of Metalloproteinase-1 | 2000 |
Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Health Care Costs; Humans; Osteoarthritis; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing | 2001 |